AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Trastuzumab Emtansine in Nigeria
2 products registered with NAFDAC — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Kadcyla Powder for Concentrate for Solution for Infusion 100 mg** Powder for concentrate for solution for infusion | A6-0506 | Roche Products Limited | active | 30 May 2028 |
| Kadcyla Powder for Concentrate for Solution for Infusion 160 mg** Powder for concentrate for solution for infusion | A6-100105 | Roche Products Limited | active | 30 May 2028 |
Trastuzumab Emtansine — NAFDAC Registration Details
NAFDAC (Nigeria) has 2 registered products containing Trastuzumab Emtansine, of which 2 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Trastuzumab Emtansine registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.